Tobias Kromann-Hansen


University of California San Diego

Tobias Kromann-Hansen

Tobias Kromann-Tofting, PhD., is currently a Postdoc at the Department of Chemistry and Biochemistry at University of California San Diego. Tobias Kromann-Tofting received his PhD in Molecular Biology from Aarhus University, Denmark. Tobias Kromann-Tofting’ research is concentrated on the development of inhibitors against trypsin-like serine proteases. Working with the protease urokinase-type plasminogen activator (uPA), which is involved in progression of diseases such as arthritis and cancer, Tobias Kromann-Tofting has developed new principles for intervention with the catalytic activity of uPA by studying a new type of protease inhibitors namely singe domain antibody fragments from Camelids (Alpacas, Camels, Dromedaries and Llamas).

Follow Tobias Kromann-Hansen' at upcoming/ongoing conferences at gtcbio: